Warsaw - Delayed Quote PLN

Wasko S.A. (WAS.WA)

6.90 -0.20 (-2.82%)

At close: October 30 at 4:59:56 PM GMT+1

 All 
 News 
 Earnings Calls 
 Press Releases 
 SEC Filings 

Novartis (SWX:NOVN) Reports Longer Survival In Advanced Kidney Cancer Trial

Simply Wall St. 8h ago

NVS

ROP.SW

NOVN
St. Galler Kantonalbank (SWX:SGKN) Stock Looks Reasonable With Moderate Excess Returns

Simply Wall St. 20h ago

SGKN.SW

SGKN
3 Oil Stocks Investors Are Screening As Brent Forecasts Move Higher

Simply Wall St. 1d ago

CL=F

NG=F

HINDPETRO.NS
French Bank Stocks Under Pressure After Fitch Warning

Simply Wall St. 2d ago

CAF.PA

CRBP2.PA

CNDF.PA
All You Need to Know About Novartis (NVS) Rating Upgrade to Buy

Zacks 2d ago

NVS
Next-Generation Adeno-Associated Virus (AAV) Gene Therapy Delivery Market Report 2026 | Capitalize on $11.91B Market as Novartis, Voyager and Affinia Accelerate Engineered Capsids

GlobeNewswire 2d ago

NVS

PFE

BAYN.DE
Global Gene Silencing Therapeutics Market Report 2026-2030 | Capitalize on 16.3% CAGR as Novartis, Alnylam, Ionis, Sarepta, and Arrowhead Accelerate RNA Delivery

GlobeNewswire 2d ago

NVS

ALNY

SRPT
AstraZeneca Has an $80 Billion Dream and a Plan to Fix Its Stalling Stock

Barrons.com 2d ago

AZN

AMGN

BMY
ALNY Stock Down 25% Despite Q3 Earnings Beat on Demand Growth Concerns

Zacks 2d ago

ALNY

REGN

NVS
Is Avantor (AVTR) Stock Outpacing Its Medical Peers This Year?

Zacks 2d ago

AVTR

NVS
Eli Lilly’s tirzepatide outperforms big pharma companies in Q3

Pharmaceutical Technology 2d ago

LLY

NVS

BMY
Earnings roundup: Lilly’s unwavering momentum, Novartis’ rebound and GSK’s waiting game

BioPharma Dive 2d ago

LLY

NVS

Performance Overview

Return	WAS.WA	MSCI WORLD (^990100-USD-STRD)
YTD	+235.47%	+8.98%
1-Year	+317.34%	+9.80%
3-Year	+336.49%	--

U.S. markets open in 5h 15m

Wasko S.A. (WAS.WA)

Novartis (SWX:NOVN) Reports Longer Survival In Advanced Kidney Cancer Trial

St. Galler Kantonalbank (SWX:SGKN) Stock Looks Reasonable With Moderate Excess Returns

3 Oil Stocks Investors Are Screening As Brent Forecasts Move Higher

French Bank Stocks Under Pressure After Fitch Warning

All You Need to Know About Novartis (NVS) Rating Upgrade to Buy

Next-Generation Adeno-Associated Virus (AAV) Gene Therapy Delivery Market Report 2026 | Capitalize on $11.91B Market as Novartis, Voyager and Affinia Accelerate Engineered Capsids

Global Gene Silencing Therapeutics Market Report 2026-2030 | Capitalize on 16.3% CAGR as Novartis, Alnylam, Ionis, Sarepta, and Arrowhead Accelerate RNA Delivery

AstraZeneca Has an $80 Billion Dream and a Plan to Fix Its Stalling Stock

ALNY Stock Down 25% Despite Q3 Earnings Beat on Demand Growth Concerns

Is Avantor (AVTR) Stock Outpacing Its Medical Peers This Year?

Eli Lilly’s tirzepatide outperforms big pharma companies in Q3

Earnings roundup: Lilly’s unwavering momentum, Novartis’ rebound and GSK’s waiting game